710-1315

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
710 (USA) · Dr. Silva
consented 2013-02-27

AEs

Serious

Dropout signal

–

Adverse events

moderate assessed

Moderate ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-18 (study day 112.0); relationship: POSSIBLE

moderate assessed

Moderate ERYTHEMA — outcome: RECOVERED/RESOLVED; onset 2013-06-18 (study day 112.0); relationship: POSSIBLE

mild assessed

Mild HEADACHE — outcome: RECOVERED/RESOLVED; onset 2013-02-26 (study day -1.0); relationship: REMOTE

mild assessed

Mild PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-14 (study day 77.0); relationship: POSSIBLE

mild assessed

Mild PRURITUS — outcome: RECOVERED/RESOLVED; onset 2013-05-14 (study day 77.0); relationship: POSSIBLE

moderate assessed

Moderate RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-18 (study day 112.0); relationship: POSSIBLE

moderate assessed

Moderate RASH — outcome: RECOVERED/RESOLVED; onset 2013-06-18 (study day 112.0); relationship: POSSIBLE

Data queries

No data queries.